Streptozocin: Uses, Side Effects, and Dosage Guide

Introduction

Streptozocin (STZ) is an alkylating agent and antineoplastic drug used in the treatment of certain cancers, particularly metastatic pancreatic islet cell carcinoma and neuroendocrine tumors (NETs). It is a naturally occurring compound derived from the bacterium Streptomyces achromogenes. Streptozocin works by damaging DNA and inhibiting DNA synthesis in cancer cells, leading to cell death.

Chemical Structure and Properties

Streptozocin has the molecular formula C ₈H ₁₅N ₃O ₇ and is a white to pale yellow crystalline powder. It is a nitrosourea compound and acts as a prodrug, releasing the active metabolite methylnitrosourea. Streptozocin is soluble in water and has a melting point of 115-116°C. Its mechanism of action involves DNA alkylation and cross-linking, leading to cellular toxicity and apoptosis.

Therapeutic Uses

The primary therapeutic use of streptozocin is in the treatment of metastatic pancreatic islet cell carcinoma, a rare type of pancreatic cancer. It is also used to treat other types of NETs, such as carcinoid tumors and pheochromocytomas. Streptozocin is often used in combination with other chemotherapy drugs, such as 5-fluorouracil and doxorubicin, to enhance its efficacy. In addition to its antineoplastic properties, streptozocin is used in experimental animals to induce diabetes by selectively destroying insulin-producing beta cells in the pancreas.

Administration and Dosage

Streptozocin is administered intravenously, typically in a hospital setting under the supervision of healthcare professionals. The recommended dosage varies depending on the type of cancer being treated and the patient’s overall health. A common dosage regimen for pancreatic islet cell carcinoma is 500 mg/m² administered once daily for 5 consecutive days every 6 weeks. Dose adjustments may be necessary based on the patient’s response and tolerability. Streptozocin is available under the brand name Zanosar.

Side Effects and Toxicity

Streptozocin can cause various side effects, ranging from mild to severe. Common side effects include nausea, vomiting, diarrhea, loss of appetite, and fatigue. More severe side effects may include bone marrow suppression, leading to decreased blood cell counts, and renal toxicity. Patients receiving streptozocin should be closely monitored for signs of toxicity, and supportive care measures should be provided as needed.

Liver Toxicity

Streptozocin can cause significant liver toxicity, known as hepatotoxicity. This may manifest as elevated liver enzymes, hepatitis, or even liver failure in severe cases. Regular monitoring of liver function is crucial during streptozocin treatment. If signs of liver toxicity are observed, dose adjustments or discontinuation of the drug may be necessary. Patients with pre-existing liver impairment may require special precautions or may not be suitable candidates for streptozocin therapy.

Usage in Research

Apart from its clinical applications, streptozocin is widely used in medical research, particularly in the field of diabetes. It is used to create experimental models of diabetes in animals by selectively destroying the insulin-producing beta cells in the pancreas. This allows researchers to study the pathophysiology of diabetes and develop new therapeutic approaches. Streptozocin-induced diabetes models have contributed significantly to our understanding of the disease and the development of antidiabetic drugs.

Clinical Studies and Trials

Several clinical studies and trials have been conducted to evaluate the efficacy and safety of streptozocin in various cancers. A phase III trial published in the New England Journal of Medicine demonstrated that the combination of streptozocin and doxorubicin improved response rates and survival in patients with advanced pancreatic islet cell carcinoma compared to streptozocin alone. Other studies have investigated the use of streptozocin in combination with other chemotherapy agents and targeted therapies to enhance treatment outcomes.

Conclusion

Streptozocin is an important antineoplastic drug used in the treatment of certain cancers, particularly pancreatic islet cell carcinoma and neuroendocrine tumors. Its mechanism of action involves DNA damage and inhibition of DNA synthesis, leading to cancer cell death. While streptozocin can be an effective treatment option, it is associated with potential side effects and toxicities, including liver toxicity, which require close monitoring and management. Ongoing research continues to explore the potential of streptozocin in combination with other therapies to improve cancer treatment outcomes.